Catalyst Capital Advisors LLC Sells 525 Shares of KKR & Co. Inc. (NYSE:KKR)

Catalyst Capital Advisors LLC reduced its position in shares of KKR & Co. Inc. (NYSE:KKR) by 22.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,855 shares of the asset manager’s stock after selling 525 shares during the period. Catalyst Capital Advisors LLC’s holdings in KKR & Co. Inc. were worth $242,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Versant Capital Management Inc raised its stake in shares of KKR & Co. Inc. by 622.9% in the second quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock valued at $27,000 after acquiring an additional 218 shares during the last quarter. Mather Group LLC. raised its position in KKR & Co. Inc. by 371.4% in the 2nd quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock valued at $27,000 after purchasing an additional 208 shares during the last quarter. ORG Wealth Partners LLC bought a new position in KKR & Co. Inc. in the 3rd quarter valued at $31,000. Raleigh Capital Management Inc. boosted its stake in KKR & Co. Inc. by 56.7% in the third quarter. Raleigh Capital Management Inc. now owns 235 shares of the asset manager’s stock worth $31,000 after purchasing an additional 85 shares in the last quarter. Finally, Eastern Bank bought a new position in shares of KKR & Co. Inc. in the third quarter valued at about $34,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at KKR & Co. Inc.

In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the stock in a transaction on Wednesday, September 11th. The stock was acquired at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the purchase, the insider now directly owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. 39.34% of the stock is owned by insiders.

KKR & Co. Inc. Stock Up 1.6 %

Shares of NYSE:KKR opened at $138.99 on Wednesday. The company has a 50 day moving average price of $131.06 and a two-hundred day moving average price of $116.32. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market capitalization of $123.35 billion, a PE ratio of 42.25, a PEG ratio of 1.14 and a beta of 1.61. KKR & Co. Inc. has a 52 week low of $58.94 and a 52 week high of $147.15.

KKR & Co. Inc. (NYSE:KKR) last released its quarterly earnings data on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35. The business had revenue of $4.79 billion during the quarter, compared to analysts’ expectations of $1.23 billion. KKR & Co. Inc. had a net margin of 13.21% and a return on equity of 5.86%. During the same quarter in the prior year, the company earned $0.73 EPS. Analysts forecast that KKR & Co. Inc. will post 4.01 earnings per share for the current year.

KKR & Co. Inc. Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be issued a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a dividend yield of 0.50%. The ex-dividend date is Monday, November 4th. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 21.28%.

Analysts Set New Price Targets

A number of equities research analysts have commented on KKR shares. Citigroup increased their price objective on shares of KKR & Co. Inc. from $157.00 to $171.00 and gave the stock a “buy” rating in a report on Friday, October 25th. Oppenheimer raised their price target on shares of KKR & Co. Inc. from $128.00 to $148.00 and gave the company an “outperform” rating in a report on Wednesday, October 16th. HSBC began coverage on KKR & Co. Inc. in a report on Wednesday, September 18th. They set a “buy” rating and a $148.00 price objective on the stock. The Goldman Sachs Group lifted their target price on KKR & Co. Inc. from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Friday, October 25th. Finally, Evercore ISI upped their price target on KKR & Co. Inc. from $135.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $151.64.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.